Why Farbe Firma is the Top Manufacturer of Promethazine HCl Injection
- Maulik Sudani
- 2 days ago
- 8 min read
Last Updated: June 17, 2026
TL;DR: Promethazine HCl Injection — a sterile, clear, colourless to very faintly coloured aqueous solution of promethazine hydrochloride, a phenothiazine-derivative first-generation H1 antihistamine with marked antiemetic, sedative and anticholinergic properties, supplied commonly as a 25 mg/mL ampoule (also 50 mg/mL) for deep intramuscular use and, with caution, slow intravenous use — is a versatile hospital agent for nausea and vomiting, allergic reactions, sedation, motion sickness and as an adjunct in peri-operative care. Because promethazine is light-sensitive and oxidation-prone and intravenous use carries a real risk of severe tissue injury, each ampoule must deliver an exact, sterile, particulate-free dose at a tightly controlled concentration, with the assay, the impurity and degradation profile, solution pH, colour, fill volume, low particulate and endotoxin, a validated sterilisation route and verified container-closure integrity all mattering to safety and shelf life. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Promethazine HCl Injection at our Gujarat, India facility and supplies it to hospital pharmacy, emergency, anaesthesia, allergy and supportive-care services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Phenothiazine-derivative first-generation H1 antihistamine with antiemetic, sedative and anticholinergic action — Promethazine HCl Injection is given by deep intramuscular injection (and, with caution, slow intravenous injection) for nausea and vomiting, allergic reactions, sedation, motion sickness and as a peri-operative adjunct.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, dedicated solution compounding and amber-glass ampoule filling lines under nitrogen protection, control of the stability-indicating assay, the oxidation and degradation profile, solution colour and pH, fill volume, particulate and endotoxin, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, sterilisation and container-closure data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile-solution contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready ampoule packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Promethazine HCl Injection Demands a Premium Manufacturer
Promethazine HCl Injection holds a versatile, everyday place in emergency departments, operating theatres, allergy clinics and general wards across every market. It is the parenteral phenothiazine antihistamine that clinicians reach for when several effects are needed at once — to settle nausea and vomiting, to calm an acute allergic reaction, to provide sedation, to manage motion sickness, and to act as a sedative and antiemetic adjunct around surgery and procedures. As a first-generation H1 antagonist with additional antimuscarinic and central depressant activity, promethazine blocks histamine at the H1 receptor while damping the vomiting centre and producing useful sedation. In each of these settings the dose delivered from each ampoule must be exact, sterile, particulate-free and reliably the same from unit to unit, because predictable sedation and antiemetic cover depend on a precise, reproducible dose delivered in a small volume.
That clinical reality places real demands on the manufacturer. Promethazine is intrinsically light-sensitive and readily oxidised, discolouring from clear and colourless toward a faint blue-pink tint as it degrades — so the product must be protected with an antioxidant system, a chelating agent, an inert-gas headspace and amber glass, and held within a tightly defined acidic pH window throughout shelf life. The assay of promethazine must be exact; the oxidation and degradation profile must stay within tight limits; the solution colour, pH and the deliverable volume must be controlled so each ampoule gives the labelled dose at the labelled concentration; the solution must be free of visible and sub-visible particulates and low in endotoxin; and because intravenous administration carries a recognised risk of severe local tissue injury on extravasation or inadvertent intra-arterial injection, the concentration and labelling must be controlled with particular care. Choosing a Promethazine HCl Injection manufacturer that treats photostability, the antioxidant and pH system, the stability-indicating assay, particulate and endotoxin control and container-closure integrity as core engineering disciplines is what protects the patient at the point of care.
What Sets a World-Class Promethazine HCl Injection Manufacturer Apart
A world-class manufacturer of Promethazine HCl Injection invests in three areas that weaker suppliers underfund: a precise, stability-indicating assay of promethazine with the tight related-substance, oxidation- and degradation-product control by HPLC that a light-sensitive phenothiazine parenteral demands, a robust, validated fill process under inert-gas protection in amber glass — with terminal moist-heat sterilisation where the formulation and container permit it, otherwise sterile filtration and aseptic filling — that protects the assay, the colour, the pH and the clarity of the solution, and tender-ready dossier support for a high-volume hospital-formulary product procured through pharmacy and ministry-of-health channels. It starts with the active — pharmacopoeial-grade promethazine hydrochloride sourced from qualified, audited API makers, with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production.
Compounding and filling then have to defend the assay against oxidation and light. The bulk solution is compounded in water-for-injection at the controlled acidic pH that keeps promethazine stable, with an antioxidant such as sodium metabisulfite and a chelating agent to suppress oxidation, the whole process carried out under nitrogen sparging and light protection, sterile-filtered through 0.22 µm membrane, and filled into amber-glass ampoules under ISO Class 5 conditions with a nitrogen headspace, with the validated sterilisation route — terminal moist-heat where qualified, otherwise full aseptic processing — locked in the master batch record. Filled ampoules are 100 % inspected for fill, seal, colour, clarity and particulate defects; in-process and release testing confirm the assay of promethazine by validated HPLC, the related-substance and oxidation profile, solution colour and pH, deliverable volume, visible and sub-visible particulate matter, and that endotoxin is held well within limits so the solution is safe for parenteral administration. Because the molecule oxidises and photodegrades, the antioxidant level, the inert-gas headspace and light-protected handling are validated together so colour and degradation stay within specification across shelf life.
Quality Systems Behind Every Promethazine HCl Injection
Every Farbe Firma Promethazine HCl Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of promethazine against pharmacopoeial reference standards, control of related substances, oxidation and degradation products by HPLC, solution colour and clarity, solution pH, antioxidant content, deliverable (fill) volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the amber-glass ampoule format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated sterilisation and depyrogenation equipment, validated ampoule-filling lines with nitrogen purge and 100 % inspection, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because promethazine is intensely light-sensitive and oxidation-prone and the assay, colour, pH and particulate burden of the solution drive both efficacy and safety, we treat the stability-indicating HPLC assay, the oxidation and degradation profile, the solution colour and pH and the deliverable volume as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under both long-term (25 °C / 60 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions, with ICH Q1B photostability challenge that specifically demonstrates the protection given by the amber glass and antioxidant system.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Promethazine HCl Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a broad small-volume parenteral portfolio across emergency, anaesthesia, allergy, antiemetic and supportive-care categories. For Promethazine HCl Injection specifically, we supply the 25 mg/mL and 50 mg/mL ampoule of sterile solution in amber glass under WHO-GMP conditions, with country-specific strengths, fill configurations, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier — including the stability-indicating-assay, photostability, antioxidant, sterilisation and container-closure data package — ready to hand for registration and tender qualification.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, sterilisation and container-closure reports, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Promethazine HCl Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment plan delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, stability-indicating assay development, oxidation and photodegradation control, antioxidant and chelator selection, pH and buffer design, nitrogen-purge and amber-glass strategy, the choice between terminal sterilisation and aseptic filling, fill-volume and deliverable-dose control, concentration and labelling controls that address the intravenous tissue-injury risk, particulate and endotoxin control, container-closure integrity and shelf-life choices in real detail. For a light-sensitive, oxidation-prone parenteral antihistamine where assay accuracy, colour, photostability and particulate control directly govern both efficacy and safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Promethazine HCl Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Promethazine HCl Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, dedicated solution compounding and amber-glass ampoule filling lines under nitrogen protection, validated sterilisation, qualified water-for-injection systems, 100 % inspection and continuous environmental monitoring.
Which strengths and pack sizes of Promethazine HCl Injection do you supply?
Our standard presentations are the 25 mg/mL and 50 mg/mL ampoule of sterile promethazine hydrochloride solution in amber glass, for deep intramuscular use and, with caution, slow intravenous use. Custom strengths, fill configurations, ampoule formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
What is Promethazine HCl Injection mainly used for?
Promethazine HCl Injection is used for nausea and vomiting, allergic reactions, sedation, motion sickness and as a sedative and antiemetic adjunct in peri-operative care. It is a phenothiazine first-generation H1 antihistamine with antiemetic, sedative and anticholinergic action; Farbe Firma verifies the assay, colour, clarity, deliverable volume, pH and particulate matter at release so each ampoule delivers a precise, reproducible dose.
Can Farbe Firma support country-specific registrations for Promethazine HCl Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Promethazine HCl Injection contract manufacturing?
MOQs vary by strength, ampoule size, sterilisation route, label complexity and dossier requirements. For our small-volume parenteral presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments